Literature DB >> 16393236

Gut microflora associated characteristics in children with celiac disease.

B Tjellström1, L Stenhammar, L Högberg, K Fälth-Magnusson, K-E Magnusson, T Midtvedt, T Sundqvist, E Norin.   

Abstract

OBJECTIVES: The aim of the study was to investigate the metabolic function of intestinal microflora in children with celiac disease (CD) in order to find out if there is a deviant gut flora in CD patients compared to healthy controls.
METHODS: The study group comprised children with CD, consecutively diagnosed according to current criteria given by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. Thirty-six children were studied at presentation, i.e., on a normal gluten-containing diet, with clinical symptoms and signs indicative of CD, positive celiac serology markers, and a small bowel biopsy showing severe enteropathy. Forty-seven patients were studied when they had been on a gluten-free diet (GFD) for at least 3 months. For comparison, a group of 42 healthy controls (HC) were studied. The functional status of the intestinal microflora was evaluated by gas-liquid chromatography of short chain fatty acids (SCFAs) in fecal samples.
RESULTS: There was a significant difference between untreated CD children and HC as well as between treated CD children and HC regarding acetic, i-butyric, i-valeric acid, and total SCFAs. The propionic and n-valeric acids differed significantly between CD children on GFD and HC. Moreover, there was a strong correlation between i-butyric and i-valeric acids in all study groups.
CONCLUSIONS: This is the first study of the SCFA pattern in fecal samples from children with CD. The results indicate that there is a difference in the metabolic activity of intestinal microbial flora in children with CD compared to that in HC. The finding of a different pattern of some SCFAs in celiacs both at presentation and during treatment with GFD indicates that it is a genuine phenomenon of CD not affected by either the diet, the inflammation, or the autoimmune status of the patient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16393236     DOI: 10.1111/j.1572-0241.2005.00313.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  42 in total

Review 1.  Clinical metabolomics paves the way towards future healthcare strategies.

Authors:  Sebastiano Collino; François-Pierre J Martin; Serge Rezzi
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder.

Authors:  Lv Wang; Claus Thagaard Christophersen; Michael Joseph Sorich; Jacobus Petrus Gerber; Manya Therese Angley; Michael Allan Conlon
Journal:  Dig Dis Sci       Date:  2012-04-26       Impact factor: 3.199

3.  Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children.

Authors:  Giada De Palma; Inmaculada Nadal; Marcela Medina; Ester Donat; Carmen Ribes-Koninckx; Miguel Calabuig; Yolanda Sanz
Journal:  BMC Microbiol       Date:  2010-02-24       Impact factor: 3.605

Review 4.  Gut microbes and adverse food reactions: Focus on gluten related disorders.

Authors:  Heather J Galipeau; Elena F Verdu
Journal:  Gut Microbes       Date:  2014

Review 5.  Innate immunity: actuating the gears of celiac disease pathogenesis.

Authors:  Sangman Michael Kim; Toufic Mayassi; Bana Jabri
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-11       Impact factor: 3.043

6.  A gluten metabolism study in healthy individuals shows the presence of faecal glutenasic activity.

Authors:  Alberto Caminero; Esther Nistal; Laura Arias; Santiago Vivas; Isabel Comino; Ana Real; Carolina Sousa; José M Ruiz de Morales; Miguel A Ferrero; Leandro B Rodríguez-Aparicio; Javier Casqueiro
Journal:  Eur J Nutr       Date:  2011-06-14       Impact factor: 5.614

Review 7.  Triggers and drivers of autoimmunity: lessons from coeliac disease.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Nat Rev Immunol       Date:  2013-03-15       Impact factor: 53.106

Review 8.  Upper gastrointestinal microbiota and digestive diseases.

Authors:  Zi-Kai Wang; Yun-Sheng Yang
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

9.  A distinctive 'microbial signature' in celiac pediatric patients.

Authors:  Serena Schippa; Valerio Iebba; Maria Barbato; Giovanni Di Nardo; Valentina Totino; Monica Proietti Checchi; Catia Longhi; Giulia Maiella; Salvatore Cucchiara; Maria Pia Conte
Journal:  BMC Microbiol       Date:  2010-06-17       Impact factor: 3.605

10.  Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for coeliac disease?

Authors:  A Bas; G Forsberg; V Sjöberg; S Hammarström; O Hernell; M-L Hammarström
Journal:  Gut       Date:  2008-02-25       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.